LSV Asset Management Has $1.95 Million Holdings in Phibro Animal Health Co. (NASDAQ:PAHC)

LSV Asset Management decreased its position in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 14.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 92,900 shares of the company's stock after selling 15,500 shares during the quarter. LSV Asset Management owned about 0.23% of Phibro Animal Health worth $1,951,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Hussman Strategic Advisors Inc. acquired a new position in shares of Phibro Animal Health during the fourth quarter worth approximately $2,205,000. Alliancebernstein L.P. boosted its holdings in Phibro Animal Health by 357.1% in the 4th quarter. Alliancebernstein L.P. now owns 130,000 shares of the company's stock valued at $2,730,000 after purchasing an additional 101,560 shares during the period. Prudential Financial Inc. grew its position in Phibro Animal Health by 405.8% in the 4th quarter. Prudential Financial Inc. now owns 120,655 shares of the company's stock worth $2,534,000 after purchasing an additional 96,800 shares during the last quarter. American Century Companies Inc. increased its holdings in shares of Phibro Animal Health by 18.0% during the 4th quarter. American Century Companies Inc. now owns 635,599 shares of the company's stock worth $13,348,000 after purchasing an additional 96,787 shares during the period. Finally, Massachusetts Financial Services Co. MA bought a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $2,020,000. Institutional investors and hedge funds own 99.34% of the company's stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on PAHC. Morgan Stanley set a $20.00 price target on Phibro Animal Health in a research note on Tuesday, April 15th. Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the company an "underweight" rating in a research note on Monday, February 10th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "buy" rating to a "hold" rating in a research note on Tuesday, March 25th. Two research analysts have rated the stock with a sell rating and three have given a hold rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has an average rating of "Hold" and an average price target of $19.75.

Phibro Animal Health Price Performance

Shares of PAHC traded up $0.46 during mid-day trading on Friday, reaching $17.29. The company had a trading volume of 241,189 shares, compared to its average volume of 191,577. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. The company has a market capitalization of $700.30 million, a P/E ratio of 36.02, a P/E/G ratio of 0.45 and a beta of 0.63. Phibro Animal Health Co. has a twelve month low of $12.30 and a twelve month high of $26.55. The company's 50-day moving average is $21.46 and its 200-day moving average is $22.30.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, equities analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current year.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.78%. Phibro Animal Health's dividend payout ratio is 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.